A prospective, multi-center, randomized, double blinded, placebo-controlled study for the evaluation of Iloprost in the early postoperative period after liver transplantation - PRAISE-Study

Trial Profile

A prospective, multi-center, randomized, double blinded, placebo-controlled study for the evaluation of Iloprost in the early postoperative period after liver transplantation - PRAISE-Study

Completed
Phase of Trial: Phase III

Latest Information Update: 12 Sep 2016

At a glance

  • Drugs Iloprost (Primary)
  • Indications Ischaemia; Thrombosis
  • Focus Pharmacodynamics
  • Acronyms PRAISE
  • Most Recent Events

    • 27 Feb 2016 Status changed from recruiting to completed as reported by ISRCTN record.
    • 16 Jul 2012 Trial design presented at the 24th International Congress of the Transplantation Society.
    • 11 Apr 2012 Additional trial centres and trial conpanies (Bayer Vital, Astellas Pharma) added as reported by German Clinical Trials Register.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top